Tesla Looks to End 3-Day Skid, Pharma Stock Plunges 50% After Pfizer Ends Partnership
The Rundown
00:00
Vistra's Rise Amidst Nuclear Energy Revival and Tesla's Stock Dynamics
This chapter explores Vistra's impressive performance as a leading stock in 2024, fueled by a growing demand for nuclear energy from AI data centers. It also examines Tesla's challenges amid stock declines and their upcoming delivery numbers that are vital for their growth.
Transcript
Play full episode
